Escape from humoral immunity is associated with treatment failure in HIV-1-infected patients receiving long-term antiretroviral therapy
Abstract Interindividual heterogeneity in the disease progression of HIV-1-infected patients receiving long-term antiretroviral therapy suggests that some host-related factors may have limited treatment efficacy. To understand the nature of factors contributing to treatment failure, we performed a r...
Guardado en:
Autores principales: | Yabo Ouyang, Qianqian Yin, Wei Li, Zhenpeng Li, Desheng Kong, Yanling Wu, Kunxue Hong, Hui Xing, Yiming Shao, Shibo Jiang, Tianlei Ying, Liying Ma |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0a9c0dd248034bcfa50ff8cdab280a48 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
One-domain CD4 Fused to Human Anti-CD16 Antibody Domain Mediates Effective Killing of HIV-1-Infected Cells
por: Wei Li, et al.
Publicado: (2017) -
Effects of high CD4 cell counts on death and attrition among HIV patients receiving antiretroviral treatment: an observational cohort study
por: Zhenzhu Tang, et al.
Publicado: (2017) -
Time to Develop and Predictors for Incidence of Tuberculosis among Children Receiving Antiretroviral Therapy
por: Fassikaw Kebede, et al.
Publicado: (2021) -
The incidence and types of medication errors in patients receiving antiretroviral therapy in resource-constrained settings.
por: Kenneth Anene Agu, et al.
Publicado: (2014) -
Pre-Existing Humoral Immunological Memory Is Retained in Patients with Multiple Sclerosis Receiving Cladribine Therapy
por: Tobias Moser, et al.
Publicado: (2021)